Alexion

Alexion dumps ex-Achillion C3G program after seeing phase 2 data
Fierce Biotech
Thu, 07/30/20 - 11:01 am
Alexion
Achillion
M&A
clinical trials
Biopharma takeovers show quantity, if not quality
EP Vantage
Mon, 07/13/20 - 11:13 am
COVID-19
pandemic
M&A
Novo Nordisk
Corvidia
Gilead Sciences
Pionyr
Alexion
Portola Pharmaceuticals
Menarini
Stemline Therapeutics
Shionogi
Tetra Therapeutics
Genentech posts long-term data on near-approval Soliris rival
Fierce Biotech
Fri, 05/22/20 - 10:46 am
Genentech
satralizumab
Soliris
Alexion
NMOSD
Martin Mackay’s rare disease startup gets $145 million as it enters the clinic
Endpoints
Tue, 05/19/20 - 10:42 am
Martin Mackay
Alexion
rare disease
Rallybio
FNAIT
(Another) activist attack on Alexion, as Paul Singer-founded hedge fund calls for biotech to sell itself
Endpoints
Wed, 05/13/20 - 11:16 am
Alexion
Paul Singer
activists
Alexion Pharma to Buy Portola for $18-Share, or $1.41 Billion
TheStreet.com
Tue, 05/5/20 - 11:08 am
Alexion
M&A
Portola Pharmaceuticals
AndexXa
EMA gives thumbs up to key drugs from Novartis, Alexion, Vertex and more
Endpoints
Fri, 05/1/20 - 12:43 pm
EMA
Europe
Novartis
Alexion
Vertex Pharmaceuticals
Alexion trials rare disease drug Ultomiris in severe COVID-19 cases
Pharmaforum
Tue, 04/21/20 - 12:28 pm
Alexion
Ultomiris
COVID-19
Alexion to start Phase III study of blood disorder drug in Covid-19 respiratory disease
MedCity News
Mon, 04/20/20 - 10:40 am
Alexion
COVID-19
Ultomiris
clinical trials
Alexion plans phase 2 study of Soliris in COVID-19 in coming days: report
Fierce Pharma
Tue, 04/7/20 - 07:10 pm
Alexion
COVID-19
clinical trials
Soliris
Who were biopharma's Q4 growth stars? Vertex, thanks to a new launch, plus Alexion, Regeneron and GSK
Fierce Pharma
Sat, 02/29/20 - 07:13 pm
Vertex Pharmaceuticals
Alexion
Regeneron
GSK
earnings
One less rival for Immunovant, as Alexion abandons FcRn inhibitor
Endpoints
Wed, 02/26/20 - 10:36 am
Alexion
anti-FcRn
Immunovant
Alexion to Start Pivotal Study on Ultomiris for ALS in Q1
Yahoo/Zacks.com
Thu, 01/16/20 - 10:14 am
Alexion
ALS
Ultomiris
clinical trials
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
Sat, 01/11/20 - 11:02 pm
JPMHC 2020
Bristol-Myers Squibb
Vertex Pharmaceuticals
Biomarin
Regeneron
Biogen
Alexion
Gilead Sciences
Amgen
Drugmakers rebranding around oncology, rare diseases could provide 2020 preview
Fierce Pharma
Thu, 12/19/19 - 11:32 pm
oncology
Rare Diseases
AstraZeneca
GSK
Alexion
Takeda
Soliris
Alexion shoots down 'proactive' sale demand from activist investor
Fierce Pharma
Fri, 12/6/19 - 10:42 am
Alexion
investors
M&A
Roche's Chugai claims Alexion co-opted its patented tech in building Ultomiris
Fierce Pharma
Wed, 11/13/19 - 11:24 pm
Alexion
Chugai
Roche
Ultomiris
patents
FDA approves Alexion's Ultomiris for another rare blood disease
Yahoo/Reuters
Sun, 10/20/19 - 05:31 pm
Alexion
FDA
Ultomiris
aHUS
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
Yahoo/Benzinga
Sun, 10/20/19 - 05:18 pm
earnings
Eli Lilly
Alexion
Gilead Sciences
Biomarin
Edwards Lifesciences
Baxter International
Integra LifeSciences
Phathom Pharmaceuticals
IPOs
Foamix
Eton Pharmaceuticals
Melinta Therapeutics
Ligand Pharmaceuticals
The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings
Yahoo/Benzinga
Mon, 10/14/19 - 09:43 am
JNJ
Flexion Therapeutics
Novartis
Amgen
Clearside Biomedical
Alexion
Assertio Therapeutics
Aldeyra Therapeutics
Lineage Therapeutics
IMMUTEP
Marinus Pharma

Pages